{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:09:17Z","timestamp":1776082157432,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.urolonc.2015.01.021","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T01:00:56Z","timestamp":1425517256000},"page":"203.e19-203.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Nigel P.","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Fuentealba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Badilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.01.021_bib1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1852::AID-CNCR25>3.0.CO;2-3","article-title":"The early detection of prostate carcinoma with PSA","volume":"80","author":"Smith","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.01.021_bib2","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.23908","article-title":"An updated catalog of prostate cancer predictive tools","volume":"113","author":"Shariat","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.01.021_bib3","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/01.ju.0000158039.94467.5d","article-title":"Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum PSA","volume":"173","author":"Karakiewicz","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/pros.22470","article-title":"A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy","volume":"72","author":"Ouzaid","year":"2012","journal-title":"The Prostate"},{"key":"10.1016\/j.urolonc.2015.01.021_bib5","first-page":"6110","article-title":"Detection of hematogenous micrometastasis in patients with prostate cancer","volume":"52","author":"Moreno","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.01.021_bib6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00000478-200207000-00012","article-title":"Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions","volume":"26","author":"Zhou","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00000478-200212000-00006","article-title":"P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies","volume":"26","author":"Beach","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib8","first-page":"8","article-title":"A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men","author":"Murray","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.urolonc.2015.01.021_bib9","first-page":"6","article-title":"Primary circulating prostate cells are not detected in men with low grade small volume prostate cancer","author":"Murray","year":"2014","journal-title":"J Oncol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib10","unstructured":"Campbell MF, Wein AJ, Kavoussi LR. Campbell's urology. In: Wein A, Kavoussi LR, Novick A et al., editors. Campbell-Walsh Urology. 10th Ed. 2006: Madrid; Elsevier [chapter 3]."},{"key":"10.1016\/j.urolonc.2015.01.021_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0032472031000141283","article-title":"Standardization of the immunocytochemical detection of cancer cells in BM and blood. I. Establishment of objective criteria for the evaluation of immunostained cells","volume":"1","author":"Borgen","year":"1999","journal-title":"Cytotherapy"},{"key":"10.1016\/j.urolonc.2015.01.021_bib12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/jama.287.13.1662","article-title":"\u03b1-Methylacyl Coenzyme-A racemase as a tissue biomarker for prostate cancer","volume":"287","author":"Rubin","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2015.01.021_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11255-009-9622-1","article-title":"Evaluation of routine applications of P504S, 34\u03b2E12 and p63 immunostaining on 250 prostate needle biopsy specimens","volume":"42","author":"Pavlakis","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2015.01.021_bib15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/dji205","article-title":"PSA levels in the United States. Implications of various definitions for abnormal","volume":"97","author":"Welch","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2015.01.021_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2015.01.021_bib17","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1002\/cncr.24446","article-title":"Anxiety and distress during active surveillance for early prostate cancer","volume":"115","author":"van den Bergh","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2015.01.021_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0090-4295(97)00100-3","article-title":"Complications of transrectal ultrasound guided systematic sextant biopsies of prostate: evaluation of complication rates and risk factors within a population based screening population","volume":"49","author":"Rietbergen","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.01.021_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.bjc.6604912","article-title":"Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study","volume":"100","author":"Eschw\u00e8ge","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2015.01.021_bib20","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.juro.2008.01.102","article-title":"Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer","volume":"179","author":"Davis","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib21","first-page":"25","article-title":"Isolation and characterization of circulating tumor cell from patients with localized and metastatic prostate cancer","volume":"25","author":"Stott","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.urolonc.2015.01.021_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/annonc\/mdl419","article-title":"High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity","volume":"18","author":"Fizazi","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCam protein expression in human carcinomas","volume":"1","author":"Went","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2006.12.014","article-title":"Circulating tumor cells (CTC) detection: clinical impact and future directions","volume":"253","author":"Paterlini-Brechot","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.urolonc.2015.01.021_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10549-011-1373-x","article-title":"Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients","volume":"130","author":"Raimondi","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.urolonc.2015.01.021_bib26","first-page":"5","article-title":"Circulating prostate cells found in men with benign prostate disease are P504S negative: clinical implications","author":"Murray","year":"2013","journal-title":"J Oncol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2119\/molmed.2008.00116","article-title":"Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls andclinical relevance","volume":"15","author":"Panteleakou","year":"2009","journal-title":"Mol Med"},{"key":"10.1016\/j.urolonc.2015.01.021_bib28","first-page":"277","article-title":"Cost benefit of the use of circulating prostate cells to detect prostate cancer","volume":"66","author":"Murray","year":"2013","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.urolonc.2015.01.021_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3892\/or_00000908","article-title":"P504S expressing circulating prostate cells as a marker for prostate cancer","volume":"24","author":"Murray","year":"2010","journal-title":"Oncol Rep"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:31:23Z","timestamp":1776079883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1078143915000551"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.01.021","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}